PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION

• Antonella Mancusi,
• Francesco Zorutti,
• Loredana Ruggeri,
• Samanta Bonato,
• Sara Tricarico,
• Tiziana Zei,
• Roberta Iacucci Ostini,
• Valerio Viglione,
• Rebecca Sembenico,
• Valeria Cardinali,
• Massimo Fabrizio Martelli,
• Cristina Mecucci,
• Maria Paola Martelli,
• Alessandra Carotti,
• Andrea Velardi,
• Antonio Pierini

Affiliations

Antonella Mancusi

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Francesco Zorutti

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Loredana Ruggeri

2 Ospedale Santa Maria della Misericordia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Samanta Bonato

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Sara Tricarico

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Tiziana Zei

2 Ospedale Santa Maria della Misericordia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Roberta Iacucci Ostini

2 Ospedale Santa Maria della Misericordia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Valerio Viglione

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Rebecca Sembenico

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Valeria Cardinali

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Massimo Fabrizio Martelli

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Cristina Mecucci

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Maria Paola Martelli

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Alessandra Carotti

2 Ospedale Santa Maria della Misericordia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Andrea Velardi

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy

Antonio Pierini

1 University of Perugia, Medicine and Surgery, Division of Hematology and Clinical Immunology, Perugia, Italy